PharmaSGP Holding SE (PSG) — Cash Flow-to-Debt Ratio
PharmaSGP Holding SE (PSG) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2025, meaning its operating cash flow of €4.22 Million could theoretically repay 0% of its total liabilities (€81.51 Million) in one year. See PharmaSGP Holding SE (PSG) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaSGP Holding SE Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for PharmaSGP Holding SE across 10 annual periods. Also explore PSG net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PharmaSGP Holding SE (2014–2024)
Year-by-year debt coverage analysis for PharmaSGP Holding SE. For market capitalisation and broader financial context, see market cap of PharmaSGP Holding SE.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | €24.88 Million | €82.31 Million | ▲ +3.9% |
| 2023 | 0.29x | €26.64 Million | €91.55 Million | ▲ +15.4% |
| 2022 | 0.25x | €24.71 Million | €98.01 Million | ▲ +91.7% |
| 2021 | 0.13x | €12.24 Million | €93.06 Million | ▼ -88.6% |
| 2020 | 1.15x | €15.46 Million | €13.44 Million | ▼ -46.8% |
| 2019 | 2.16x | €17.63 Million | €8.16 Million | ▲ +234.8% |
| 2017 | 0.65x | €14.25 Million | €22.09 Million | ▲ +308.7% |
| 2016 | 0.16x | €3.55 Million | €22.47 Million | ▼ -65.0% |
| 2015 | 0.45x | €10.59 Million | €23.46 Million | ▲ +68.0% |
| 2014 | 0.27x | €5.41 Million | €20.13 Million | — |